EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meibomian Gland Dysfunction and Inflammatory Ocular Surface Changes Associated with Chronic Dermatoses

Paweł Pazdrowski, Julia Woźna, Aleksandra Dańczak-Pazdrowska, Marcin Stopa

Journal of Clinical Medicine · 10.11.2026 · 15 (22) · 8794

DOI: 10.3390/jcm15228794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.11.2026. Verfasst von Paweł Pazdrowski und 3 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammatory dermatoses are increasingly recognized as systemic diseases whose manifestations may also involve the eye. One of the most commonly observed ophthalmic abnormalities is meibomian gland dysfunction (MGD), which leads to tear film instability, dry eye disease, and chronic ocular surface inflammation. This review aimed to summarize the current evidence on the association between chronic dermatoses and MGD, as well as inflammatory changes in the ocular surface. This article is a narrative review of the literature. The analysis was based on publications identified through PubMed and supplementary Europe PMC searches up to October 2026, including clinical studies, meta-analyses, and review articles addressing MGD in chronic dermatoses. Small clinical studies describe an association between MGD and rosacea, in which meibomian gland dysfunction represents one of the major mechanisms underlying ocular surface changes. A growing body of evidence also indicates an increased prevalence of MGD among patients with psoriasis and atopic dermatitis. Data on seborrheic dermatitis and hidradenitis suppurativa remain limited. Studies in seborrheic dermatitis assessed the meibomian glands. In hidradenitis suppurativa, studies reported ocular symptoms and inflammation without assessing gland structure or function. Meibomian gland abnormalities have also been reported in patients with acne vulgaris, particularly during oral isotretinoin therapy, as well as in ichthyosis, in Demodex blepharitis, and in cicatrizing disorders of the conjunctiva and eyelid margins, including Stevens–Johnson syndrome/toxic epidermal necrolysis, mucous membrane pemphigoid, and chronic ocular graft-versus-host disease. These findings indicate that, in addition to chronic inflammation, abnormal keratinization, drug-related effects, and permanent structural alterations of the ocular surface may contribute to the development of MGD. The available evidence highlights MGD as an important component of the ophthalmic manifestations of chronic dermatoses and underscores the need for close collaboration between dermatologists and ophthalmologists in the diagnosis and management of these patients. Further studies using standardized methods to assess meibomian gland function and morphology are needed to better define the role of MGD across individual dermatoses.

Förderung

  • Poznan University of Medical Sciences

Zitieren

APA

Pazdrowski, P., Woźna, J., Dańczak-Pazdrowska, A., & Stopa, M. (2026). Meibomian Gland Dysfunction and Inflammatory Ocular Surface Changes Associated with Chronic Dermatoses. Journal of Clinical Medicine, 15(22), 8794. https://doi.org/10.3390/jcm15228794

Vancouver

Pazdrowski P, Woźna J, Dańczak-Pazdrowska A, Stopa M. Meibomian Gland Dysfunction and Inflammatory Ocular Surface Changes Associated with Chronic Dermatoses. Journal of Clinical Medicine. 2026;15(22):8794. doi:10.3390/jcm15228794

BibTeX
@article{Pazdrowski2026,
  author = {Pazdrowski, Paweł and Woźna, Julia and Dańczak-Pazdrowska, Aleksandra and Stopa, Marcin},
  title = {Meibomian Gland Dysfunction and Inflammatory Ocular Surface Changes Associated with Chronic Dermatoses},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {8794},
  doi = {10.3390/jcm15228794}
}
Kostenlos starten →